Recombinant COA3 is a full-length, His-tagged protein expressed in E. coli, derived from the yeast species Vanderwaltozyma polyspora (strain DSM 70294) . It is synthesized to enable biochemical and functional studies of cytochrome oxidase assembly, a key process in mitochondrial electron transport chain regulation .
Amino Acid Sequence:
MALEPSRYLDKKTWKMTPAMIRARQPYFKKNMIALGLLLGITTGVYVYTFNLSHKDNDFIDVPIPPIDEKELAVLQKEFNDKKN .
COA3 regulates COX assembly by interacting with Cox1 (cytochrome c oxidase subunit 1) and the translational activator Mss51. Key mechanisms include:
Complex Formation: COA3, Cox14, and Mss51 form 250–400 kDa cytochrome oxidase assembly (COA) intermediates, which sequester Mss51 to suppress COX1 mRNA translation .
Feedback Regulation: COA3 and Cox14 shift Mss51 from a translation-active to a latent state, preventing excessive Cox1 synthesis and ensuring coordinated assembly .
Stability: Deletion of COA3 or COX14 destabilizes Cox1, leading to its rapid degradation .
Mitochondrial Disease Models: Used to study defects in COX assembly linked to neurodegenerative disorders .
Cancer Research: Human COA3 homologs (e.g., CCDC56) are implicated in non-small cell lung cancer (NSCLC) progression via mitochondrial fragmentation and metabolic reprogramming .
Drug Development: Target for compounds aiming to modulate oxidative phosphorylation or glycolysis in pathological states .
KEGG: vpo:Kpol_1027p21
STRING: 436907.XP_001643304.1